Column Group L P - Insider Trading & Ownership

Entity: Company
Location: 1700 Owens Street, Suite 500, San Francisco, CA
Summary: The estimated value of insider holdings of Column Group L P is at least $14.4M dollars as of April 8, 2024. Column Group L P is the 10%+ Owner of Nurix Therapeutics, Inc. and owns shares of Nurix Therapeutics, Inc. (NRIX) stock worth about $14.4M. Column Group L P is the Director, 10%+ Owner of NGM BIOPHARMACEUTICALS INC and owns shares of NGM BIOPHARMACEUTICALS INC stock worth about $1.34K.
All Insider Reports: All Insider Reports

Ownership of Column Group L P

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
NRIX	Nurix Therapeutics, Inc.	10%+ Owner	$14.4M			May 7, 2021
NGM	NGM BIOPHARMACEUTICALS INC	Director, 10%+ Owner	$1.34K			Apr 5, 2024

Showing 1 to 2 of 2 entries

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership
Loading...

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.